BTK inhibitors
Merck KGaA launches campaign to educate doctors on rare MS type, challenging Sanofi
Anika Sharma
Merck KGaA is gearing up for a significant milestone in the development of its multiple sclerosis (MS) drug candidate. As ...
Rocheās BTK inhibitor shows potential to cross blood-brain barrier in MS trial
Anika Sharma
Roche is touting its multiple sclerosis (MS) drug as a potential game-changer in the field, asserting that it has achieved ...
